Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver diseaseHONG MA; GOMEZ, Victoria; LIANG LU et al.Journal of gastroenterology and hepatology. 2009, Vol 24, Num 2, pp 233-237, issn 0815-9319, 5 p.Article

Biochemical Parameters and Anthropometry Predict NAFLD in Obese ChildrenMAFFEIS, Claudio; BANZATO, Claudia; RIGOTTI, Francesca et al.Journal of pediatric gastroenterology and nutrition. 2011, Vol 53, Num 6, pp 590-593, issn 0277-2116, 4 p.Article

Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytesSHARMA, Manju; URANO, Fumihiko; JAESCHKE, Anja et al.Journal of hepatology. 2012, Vol 56, Num 1, pp 192-198, issn 0168-8278, 7 p.Article

Phosphatidylcholine functional foods and nutraceuticals: A potential approach to prevent non-alcoholic fatty liver diseaseDURIC, Maida; SIVANESAN, Sugas; BAKOVIC, Marica et al.European journal of lipid science and technology (Print). 2012, Vol 114, Num 4, pp 389-398, issn 1438-7697, 10 p.Article

Nonalcoholic Fatty Liver Disease in Primary Aldosteronism: A Pilot StudyFALLO, Francesco; DALLA POZZA, Anna; FABRIS, Bruno et al.American journal of hypertension. 2010, Vol 23, Num 1, pp 2-5, issn 0895-7061, 4 p.Article

Influence of ethnicity on histological differences in non-alcoholic fatty liver diseaseMOHANTY, Smruti R; TROY, Tara N; DEZHENG HUO et al.Journal of hepatology. 2009, Vol 50, Num 4, pp 797-804, issn 0168-8278, 8 p.Article

Mise au point d'une stéatopathie non alcoolique = Non alcoholic fatty liver disease assessmentJURIENS, I; RIGAUX, J; BLERO, D et al.Revue médicale de Bruxelles. 2012, Vol 33, Num 4, pp 205-211, issn 0035-3639, 7 p.Conference Paper

NAFLD and hyperinsulinemia are major determinants of serum ferritin levelsZELBER-SAGI, Shira; NITZAN-KALUSKI, Dorit; HALPERN, Zamir et al.Journal of hepatology. 2007, Vol 46, Num 4, pp 700-707, issn 0168-8278, 8 p.Article

Evaluation of Aroclor 1260 exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver diseaseWAHLANG, Banrida; MING SONG; CAVE, Matthew C et al.Toxicology and applied pharmacology. 2014, Vol 279, Num 3, pp 380-390, issn 0041-008X, 11 p.Article

Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver diseaseLAKE LI; JIE HAI; ZHIQIANG LI et al.Food and chemical toxicology. 2014, Vol 63, pp 166-173, issn 0278-6915, 8 p.Article

The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studiesAL-SERRI, Ahmad; ANSTEE, Quentin M; DALY, Ann K et al.Journal of hepatology. 2012, Vol 56, Num 2, pp 448-454, issn 0168-8278, 7 p.Article

Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitisGAIA, Silvia; CARENZI, Silvia; BARILLI, Angela L et al.Journal of hepatology. 2011, Vol 54, Num 1, pp 64-71, issn 0168-8278, 8 p.Article

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severityMUSSO, Giovanni; GAMBINO, Roberto; CASSADER, Maurizio et al.Annals of medicine (Helsinki). 2011, Vol 43, Num 7-8, pp 617-649, issn 0785-3890, 33 p.Article

Noninvasive liver steatosis quantification using MRI techniques combined with blood markersCESBRON-METIVIER, Elodie; ROULLIER, Vincent; BOURSIER, Jérôme et al.European journal of gastroenterology & hepatology. 2010, Vol 22, Num 8, pp 973-982, issn 0954-691X, 10 p.Article

Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetesNARASIMHAN, Sandhya; GOKULAKRISHNAN, Kuppan; SAMPATHKUMAR, Rangasamy et al.Clinical biochemistry. 2010, Vol 43, Num 10-11, pp 815-821, issn 0009-9120, 7 p.Article

Serum Levels of CK18 M30 and Leptin Are Useful Predictors of Steatohepatitis and Fibrosis in Paediatric NAFLDFITZPATRICK, Emer; MITRY, Ragai R; QUAGLIA, Alberto et al.Journal of pediatric gastroenterology and nutrition. 2010, Vol 51, Num 4, pp 500-506, issn 0277-2116, 7 p.Article

Protective Role of Coffee in Non-alcoholic Fatty Liver Disease (NAFLD)CATALANO, Daniela; MARTINES, Giuseppe Fabio; TONZUSO, Antonia et al.Digestive diseases and sciences. 2010, Vol 55, Num 11, pp 3200-3206, issn 0163-2116, 7 p.Article

Comparison of blood tests for liver fibrosis specific or not to NAFLDCALES, Paul; LAINE, Fabrice; HENRI DUCLUZEAUX, Pierre et al.Journal of hepatology. 2009, Vol 50, Num 1, pp 165-173, issn 0168-8278, 9 p.Article

Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children : A Systematic ReviewSOCHA, Piotr; HORVATH, Andrea; VAJRO, Pietro et al.Journal of pediatric gastroenterology and nutrition. 2009, Vol 48, Num 5, pp 587-596, issn 0277-2116, 10 p.Article

The roles of obesity and gender on the relationship between metabolic risk factors and non-alcoholic fatty liver disease in KoreansLEE, Kayoung; SUNG, Jung-Ah; KIM, Jun-Su et al.Diabetes/metabolism research and reviews (Print). 2009, Vol 25, Num 2, pp 150-155, issn 1520-7552, 6 p.Article

Increased overall mortality and liver-related mortality in non-alcoholic fatty liver diseaseONG, Janus P; PITTS, Angela; YOUNOSSI, Zobair M et al.Journal of hepatology. 2008, Vol 49, Num 4, pp 608-612, issn 0168-8278, 5 p.Article

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes : An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trialsBUSE, John B; KLONOFF, David C; NIELSEN, Loretta L et al.Clinical therapeutics. 2007, Vol 29, Num 1, pp 139-153, issn 0149-2918, 15 p.Article

Nonalcoholic fatty liver disease in overweight children and adolescentsSAGI, R; REIF, S; NEUMAN, G et al.Acta paediatrica (Oslo). 2007, Vol 96, Num 8, pp 1209-1213, issn 0803-5253, 5 p.Article

Bromocriptine reduces steatosis in obese rodent modelsDAVIS, Lisa M; ZHENGTONG PEI; TRUSH, Michael A et al.Journal of hepatology. 2006, Vol 45, Num 3, pp 439-444, issn 0168-8278, 6 p.Article

Resistant Nonalcoholic Fatty Liver Disease Amelioration With Rosuvastatin and Pioglitazone Combination Therapy in a Patient With Metabolic SyndromeRICHE, Daniel M; FLEMING, Joshua W; MALINOWSKI, Scott S et al.The Annals of pharmacotherapy. 2014, Vol 48, Num 1, pp 137-141, issn 1060-0280, 5 p.Article